March and Aventis combine vaccines to combat AIDS
Merck & Co. and Aventis SA are combining their two most promising AIDS vaccines candidates in a joint human test in the U.S. that will begin later this year. For reasons neither company understands,
Merck & Co. and Aventis SA are combining their two most promising AIDS vaccines candidates in a joint human test in the U.S. that will begin later this year. For reasons neither company understands,